Press Release

<< Back

Xenon Pharmaceuticals to Participate in the Stifel 3rd Annual CNS Day

March 29, 2021

BURNABY, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced that the Company will participate in a fireside chat at the following virtual investor conference:

  • Stifel 3rd Annual CNS Day (fireside chat presentation) on Wednesday, March 31, 2021 at 1:00 pm ET

The presentation will be webcast live and archived on the “Investors” section of Xenon's website at

The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit

Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353

Primary Logo

Source: Xenon Pharmaceuticals Inc.